Gallmetzer HealthCare SpA: Strategic Growth in Dental Sector

Gallmetzer HealthCare SpA (GHC), supported by NuWays AG, has initiated coverage with a "BUY" recommendation and a 12-month target price of EUR 4.4. GHC strategically positions itself in high-margin niches, focusing on dental anesthetics and premium oral care with a sustainable twist.

Gerhò, Italy’s second-largest dental distributor, serves as a robust foundation for GHC’s operations, catering to 55,850 customers. This enduring market presence promises stable, cash-generative revenues, buoyed by a growing private-label segment.

Intermedical Pharma, a key subsidiary, enables GHC to penetrate the local anesthetics market with AIFA-approved products. This move not only enhances GHC’s value chain but also accelerates commercialization efforts.

Additionally, the premium oral care brand Promis furthers growth potential with a 70% stake. Its global expansion, notably into the US market, sets a strong precedent, complemented by the new Promis Kids line.